Correlation Between Pharmadrug and Elixinol Global

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharmadrug and Elixinol Global at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmadrug and Elixinol Global into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmadrug and Elixinol Global, you can compare the effects of market volatilities on Pharmadrug and Elixinol Global and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmadrug with a short position of Elixinol Global. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmadrug and Elixinol Global.

Diversification Opportunities for Pharmadrug and Elixinol Global

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pharmadrug and Elixinol is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Pharmadrug and Elixinol Global in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elixinol Global and Pharmadrug is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmadrug are associated (or correlated) with Elixinol Global. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elixinol Global has no effect on the direction of Pharmadrug i.e., Pharmadrug and Elixinol Global go up and down completely randomly.

Pair Corralation between Pharmadrug and Elixinol Global

Assuming the 90 days horizon Pharmadrug is expected to generate 3.46 times less return on investment than Elixinol Global. But when comparing it to its historical volatility, Pharmadrug is 2.38 times less risky than Elixinol Global. It trades about 0.07 of its potential returns per unit of risk. Elixinol Global is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  1.90  in Elixinol Global on August 29, 2024 and sell it today you would lose (1.58) from holding Elixinol Global or give up 83.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pharmadrug  vs.  Elixinol Global

 Performance 
       Timeline  
Pharmadrug 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pharmadrug has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly fragile essential indicators, Pharmadrug may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Elixinol Global 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Elixinol Global are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Elixinol Global reported solid returns over the last few months and may actually be approaching a breakup point.

Pharmadrug and Elixinol Global Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharmadrug and Elixinol Global

The main advantage of trading using opposite Pharmadrug and Elixinol Global positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmadrug position performs unexpectedly, Elixinol Global can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elixinol Global will offset losses from the drop in Elixinol Global's long position.
The idea behind Pharmadrug and Elixinol Global pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories